Evidence map›Paper›PMID 24958902›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.

Lili Chen, Eduardo Reyes-Vargas, Hu Dai, Hernando Escobar, Brant Rudd, Jared Fairbanks, Alexander Ho, Mathew F Cusick, Attila Kumánovics, Julio Delgado and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Recent advances in CD8Oncology letters · 2018
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lili ChenDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Eduardo Reyes-VargasDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Hu DaiDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Hernando EscobarARUP Laboratories, Salt Lake City, UT 84112.
Brant RuddDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Jared FairbanksDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Alexander HoDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Mathew F CusickDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and.
Attila KumánovicsDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and ARUP Laboratories, Salt Lake City, UT 84112.
Julio DelgadoDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and ARUP Laboratories, Salt Lake City, UT 84112.
Xiao HeDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and xiao.he@path.utan.edu peter.jensen@path.utah.edu.
Peter E JensenDepartment of Pathology, University of Utah, Salt Lake City, UT 84112; and ARUP Laboratories, Salt Lake City, UT 84112 xiao.he@path.utan.edu peter.jensen@path.utah.edu.
University of Utah · USARUP Laboratories (United States) · USARUP Laboratories (United States) · US

Funding

Immunity to InsulinR37AI033614 · NIAID · UNIVERSITY OF UTAH · PI JENSEN, PETER E. · 2001 to 2010
$3.4M
REGULATION OF ANTIGEN PROCESSINGR01AI030554 · NIAID · UNIVERSITY OF UTAH · PI JENSEN, PETER E. · 1991 to 2009
$3.0M
Regulation of Antigen ProcessingR21AI030554 · NIAID · UNIVERSITY OF UTAH · PI JENSEN, PETER E. · 2004 to 2004
$370k
IMMUNITY TO INSULINR01AI033614 · NIAID · EMORY UNIVERSITY · PI JENSEN, PETER E. · 1993 to 2000
$287k
NIAID NIH HHS AI30554NIAID NIH HHS AI33614NIAID NIH HHS R01 AI030554NIAID NIH HHS R01 AI033614NIAID NIH HHS R21 AI030554NIAID NIH HHS R37 AI033614
6 · The paper itself

Abstract

The mouse MHC class Ib gene H2-T11 is 95% identical at the DNA level to H2-T23, which encodes Qa-1, one of the most studied MHC class Ib molecules. H2-T11 mRNA was observed to be expressed widely in tissues of C57BL/6 mice, with the highest levels in thymus. To circumvent the availability of a specific mAb, cells were transduced with cDNA encoding T11 with a substituted α3 domain. Hybrid T11D3 protein was expressed at high levels similar to control T23D3 molecules on the surface of both TAP(+) and TAP(-) cells. Soluble T11D3 was generated by folding in vitro with Qa-1 determinant modifier, the dominant peptide presented by Qa-1. The circular dichroism spectrum of this protein was similar to that of other MHC class I molecules, and it was observed to bind labeled Qa-1 determinant modifier peptide with rapid kinetics. By contrast to the Qa-1 control, T11 tetramers did not react with cells expressing CD94/NKG2A, supporting the conclusion that T11 cannot replace Qa-1 as a ligand for NK cell inhibitory receptors. T11 also failed to substitute for Qa-1 in the presentation of insulin to a Qa-1-restricted T cell hybridoma. Despite divergent function, T11 was observed to share peptide-loading specificity with Qa-1. Direct analysis by tandem mass spectrometry of peptides eluted from T11D3 and T23D3 isolated from Hela cells demonstrated a diversity of peptides with a clear motif that was shared between the two molecules. Thus, T11 is a paralog of T23 encoding an MHC class Ib molecule that shares peptide-binding specificity with Qa-1 but differs in function.

Indexed as

AnimalsCell LineEpitopesGene Expression RegulationH-2 AntigensHeLa CellsHistocompatibility Antigens Class IHumansMiceMice, 129 StrainMice, Inbred AMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutPeptidesProtein BindingEpitopesH-2 AntigensHistocompatibility Antigens Class IPeptidesQ surface antigens

Identifiers

PMID24958902
PMCPMC4211609
OpenAlexW2131915661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.